Literature DB >> 15147956

FLT3 ligand regulates apoptosis through AKT-dependent inactivation of transcription factor FoxO3.

Maria Jönsson1, Maria Engström, Jan-Ingvar Jönsson.   

Abstract

Proliferation, differentiation, and survival of hematopoietic cells are regulated by cytokines, acting through specific receptors. FLT3 ligand (FL) is one of the most important cytokines for regulation of the hematopoietic system, and its receptor FLT3 is expressed on both stem cells and progenitors. Regulation of Forkhead transcription factors has been described as an important mechanism to control apoptosis and cell cycle progression in hematopoietic progenitors. Here we report that FL induces AKT/PKB activation, which in turn phosphorylates and thereby inactivates the Forkhead protein FoxO3 in the progenitor cell line FDC-P1 stably expressing murine FLT3 receptor. Phosphorylation of AKT and FoxO3 was blocked by the PI-3 kinase inhibitor LY294002 but not by the MAP kinase inhibitor PD98059. Expression of a mutated FoxO3, in which all three inhibitory phosphorylation sites were mutated to alanine, led to rapid increase of apoptotic cells in the presence of FL. These results suggest that FL-induced regulation of apoptosis is executed by FoxO3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147956     DOI: 10.1016/j.bbrc.2004.04.110

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  AKT1 induces caspase-mediated cleavage of the CDK inhibitor p27Kip1 during cell cycle progression in leukemia cells transformed by FLT3-ITD.

Authors:  Xinping Yang; Suiyang Liu; Surender Kharbanda; Richard M Stone
Journal:  Leuk Res       Date:  2011-12-03       Impact factor: 3.156

2.  Bortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic marker.

Authors:  Rajan Dewar; Sing-Tsung Chen; Heather Yeckes-Rodin; Kenneth Miller; Roya Khosravi-Far
Journal:  Cancer Biol Ther       Date:  2011-03-15       Impact factor: 4.742

3.  Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12.

Authors:  Sunanda Basu; Hal E Broxmeyer
Journal:  Blood       Date:  2005-03-29       Impact factor: 22.113

Review 4.  Signal transduction of oncogenic Flt3.

Authors:  Chunaram Choudhary; Carsten Müller-Tidow; Wolfgang E Berdel; Hubert Serve
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

5.  Interferon gamma has dual potential in inhibiting or promoting survival and growth of hematopoietic progenitors: interactions with stromal cell-derived factor 1.

Authors:  Jin-Hee Hwang; Seong-Woo Kim; Hyo-Jin Lee; Hwan-Jung Yun; Samyong Kim; Deog-Yeon Jo
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

Review 6.  Flt3 Signaling in B Lymphocyte Development and Humoral Immunity.

Authors:  Kay L Medina
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

7.  BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3.

Authors:  Amanda Nordigården; Maria Kraft; Pernilla Eliasson; Verena Labi; Eric W-F Lam; Andreas Villunger; Jan-Ingvar Jönsson
Journal:  Blood       Date:  2008-12-08       Impact factor: 22.113

8.  Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.

Authors:  Ellen Weisberg; Lolita Banerji; Renee D Wright; Rosemary Barrett; Arghya Ray; Daisy Moreno; Laurence Catley; Jingrui Jiang; Elizabeth Hall-Meyers; Maira Sauveur-Michel; Richard Stone; Ilene Galinsky; Edward Fox; Andrew L Kung; James D Griffin
Journal:  Blood       Date:  2008-01-09       Impact factor: 22.113

Review 9.  An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment.

Authors:  Tiziana Grafone; Michela Palmisano; Chiara Nicci; Sergio Storti
Journal:  Oncol Rev       Date:  2012-04-17

10.  Human Cytomegalovirus UL7, miR-US5-1, and miR-UL112-3p Inactivation of FOXO3a Protects CD34+ Hematopoietic Progenitor Cells from Apoptosis.

Authors:  Meaghan H Hancock; Lindsey B Crawford; Wilma Perez; Hillary M Struthers; Jennifer Mitchell; Patrizia Caposio
Journal:  mSphere       Date:  2021-01-06       Impact factor: 4.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.